Recent Finacing
Recent Raise
CRISPR Therapeutics develops CRISPR/Cas9-based gene-editing therapeutics, advancing translational programs for genetic diseases and operating R&D in Basel, Cambridge (MA), and the UK with industry collaborators.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at CRISPR Therapeutics.
